Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: A step closer toward identifying a functional clotting system in human semen

Journal of Andrology

Volumn 26, Issue 1, 2005, Pages 146-152

  Lwaleed, Bashir A ^a   Greenfield, Robert S ^b   Hicks, James ^a   Birch, Brian R ^a   Cooper, Alan J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b American Diagnostica Inc   (United States)

Author keywords

Fertility; Novel finding

Indexed keywords

BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A; PROCOAGULANT; PROSTATE SPECIFIC ANTIGEN; SEMINAL PLASMA PROTEIN; SPERM ANTIBODY;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD CLOTTING; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIQUEFACTION; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MALE INFERTILITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEMEN ANALYSIS; SPERM; SPERM DONOR; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; VASECTOMY;

ADULT; FACTOR IX; FACTOR IXA; FERTILITY; HUMANS; MALE; MIDDLE AGED; SEMEN; VASECTOMY;

EID: 10844256732     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Amelar RD. Coagulation, liquefaction and viscosity of human semen. J Urol. 1962;87:187-190.
2. Astermark J, Bjork I, Ohlin AK, Stenflo J. Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX. J Biol Chem. 1991;266:2430-2437.
3. Bajaj SP. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants. Thromb Haemost. 1999;82:218-225.
4. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361: 1801-1809.
5. Brandstetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A. 1995;92:9796-9800.
6. Briet E, Bertina RM, van Tilburg NH, Veltkamp JJ. Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty. N Engl J Med. 1982;306:788-790.
7. Bronson RA, Preissner KT. Measurement of vitronectin content of human spermatozoa and vitronectin concentration within seminal fluid. Fertil Steril. 1997;68:709-713.
8. Broze GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol. 1992;29:159-169.
9. Carson SD, De Jonge CJ. Activation of coagulation factor X in human semen. J Androl. 1998;19:289-294.
10. Christ G, Binder BR. Components of the fibrinolytic system in spermatozoa and seminal plasma of fertile and infertile men. Thromb Haemost. 1989;62:396.
11. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem. 1994;220:45-53.
12. Crossley M, Ludwig M, Stowel KM, de Vos P, Olek K, Brownlee GG. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science. 1992;257:377-379.
13. DiScipio PG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977;16:698-706.
14. DiScipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest. 1978;61:1528-1538.
15. España F, Estelles A, Fernández PJ, Gilabert J, Sanchez-Cuenca J, Griffin JH. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost. 1993;70:989-994.
16. España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res. 1991;64:309-320.
17. Fareed J, Callas DD, Hoppensteadt D, Bermes EW. Tissue factor antigen levels in various biological fluids. Blood Coag Fibrinol. 1995;6:32-36.
18. Fernández JA, Heeb MJ, Radtke K-P, Griffin JH. Potent blood coagulant activity of human semen due to prostosome-bound tissue factor. Biol Reprod. 1997;56:757-763.
19. Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem. 1995;270: 7980-7987.
20. Giannelli, F. The genetics of blood coagulation and haemostasis. In: Rizza CR, Lowe GDO, eds. Haemophilia and Other Inherited Bleeding Disorders. London: Saunders; 1997:43-86.
21. Huggins C, Neal W. Coagulation and liquefaction of semen. Proteolytic enzymes and citrate in prostatic fluid. J Exp Med. 1942;76:527-541.
22. Katayama K, Ericsson LH, Enfield DL, Walsh KA, Neurath H, Davie EW, Titani K. Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins. Proc Natl Acatl Sci U S A. 1979;76:4990-4994.
23. Kurachi K, Kurachi S. Regulatory mechanism of the factor IX gene. Thromb Haemost. 1995;73:333-339.
24. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest. 1992;89:1094-1101.
25. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest. 1985;76:1899-1903.
26. Lwaleed BA, Greenfield R, Stewart A, Birch B, Cooper AJ. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost. 2004;92:752-766.
27. Mandai A, Bhattacharyya AK. Grouping of human ejaculates according to the degree of coagulation and the relationship to the levels of choline and cholinesterase. Int J Androl. 1986;9:407-415.
28. Matsuda Y, Oshio S, Yazaki T, Umeda T, Akihama S. The effect of some proteinase inhibitors on liquefaction of human semen. Hum Reprod. 1994;9:664-668.
29. Matsuda Y, Shimokawa K, Katayama M, Shimizu H, Umeda T, Oshio S, Chiba R. Blood coagulation factor X (FX) in human seminal plasma. Arch Androl. 2002;48:295-300.
30. Neal GG, Chavin SI. The role of factors VIII and IX in the activation of bovine blood coagulation factor X. Thromb Res. 1979;16:473-484.
31. Ohta S, Wada H, Gabazza EC, Nobori T, Fuse H. Evaluation of tissue factor antigen level in human seminal plasma. Urol Res. 2002;30: 317-320.
32. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977;74:5260-5264.
33. Park JY, Yoshimara Y, Nozawa S, Umeda T, Akihama S, Matsuda Y. Fibrinogen-like substance and thrombin like enzyme in human seminal plasma: coagulation of human semen. Arch Androl. 1997;38:29-36.
34. Pavlovsky A. Contribution to the pathogenesis of hemophilia. Blood. 1947;2:185-191.
35. Polak B, Daunter B. Seminal plasma biochemistry. IV: enzymes involved in the liquefaction of human seminal plasma. Int J Androl. 1989;12: 187-194.
36. Rapaport SI, Rao LV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 1992;12:1111-1121.
37. Reiner AP, Davie EW. The physiology and biochemistry of factor IX. In: Bloom AL, Thomas DR eds. Haemostasis and Thrombosis. 3rd ed. Edinburgh: Churchill Livingstone; 1994:309-324.
38. Reitsma PH, Bertina RM, van Amstel JKP, Reimans A, Briet E. The putative factor IX gene promoter in hemophilia B Leyden. Blood. 1988;72:1074-1076.
39. Rümke P. The origin of immunoglobulins in semen. Clin Exp Immunol. 1974;17:287-297.
40. Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol. 1999;31:539-544.
41. Schwarzstein L. Male Reproduction and Fertility. New York: Raven Press; 1983.
42. Sobrero AJ, MacLeod J. The immediate postcoital test. Fertil Steril. 1962; 13:184-189.
43. Taran LD. Factor IX of the blood coagulation system: a review. Biochemistry (Mosc). 1997;62:685-693.
44. van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem. 1981;256:3433-3442.
45. van Dreden P, Gonzalez J, Poirot C. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase. Andrologia. 1991;23:29-33.
46. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678-3682.
47. van Wersch JW, De Vries-Hanje JC, Ubachs JM. Coagulation and fibri-nolysis markers in seminal plasma of patients under evaluation for involuntary childlessness. Eur J Clin Chem Clin Biochem. 1992;30: 467-471.
48. van Wersch JW, Ubachs JH, Delaere KP. Fibrinolysis and coagulation markers in seminal plasma before and after vasectomy. Fibrinolysis. 1993;7:135-138.
49. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 2000:1-128.
50. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985;24:3736-3750.